US 6979549
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein
expired A61KA61K38/1709
Quick answer
US patent 6979549 (Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein) held by Rigel Pharmaceuticals, Inc. expires Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Dec 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 52
- CPC classes
- A61K, A61K38/1709